Loading...
Blinatumomab: Enlisting serial killer T cells in the war against hematologic malignanciess
INTRODUCTION: The approval of blinatumomab signals the long awaited arrival of immunotherapy for acute lymphoblastic leukemia (ALL). Previous options for relapsed or refractory disease were restricted to combination cytotoxic chemotherapy with limited efficacy and significant toxicity. Through an in...
Na minha lista:
| Udgivet i: | Expert Opin Biol Ther |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4994468/ https://ncbi.nlm.nih.gov/pubmed/25985814 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2015.1041912 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|